William Po, MD
Obstetrics & Gynecology · Tulsa, OKNPI 1609832898
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.7%), speaking fees and education — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Organon at 41.5% of the total. Reporting peaked in 2021 at $1,437 and has fallen 85.2% since, to $213 in 2025.
Across 58 payments — averaging $60.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$1K
- AbbVie$364
- Hologic Sales And Service, LLC$290
- Baxter Healthcare$194
- Minerva Surgical, Inc$171
- Coopersurgical, Inc.$143
- plus $881 from 16 others
Across 4 payments — averaging $1050.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Viiv Healthcare Company$4K
What the payments were for
- Speaking & faculty fees$1,37539%
- Food & beverage$2,01758%
- Education$1023%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 6 | $1,452 |
| AbbVie | 9 | $364 |
| Hologic Sales And Service, LLC | 10 | $290 |
| Baxter Healthcare | 7 | $194 |
| Minerva Surgical, Inc | 2 | $171 |
| Coopersurgical, Inc. | 5 | $143 |
| Conmed Corporation | 1 | $124 |
| Si-bone, Inc. | 1 | $124 |
| Davol Inc. | 1 | $106 |
| AMAG Pharmaceuticals, Inc. | 1 | $102 |
| Boston Scientific | 1 | $73 |
| AstraZeneca | 3 | $60 |
| KCI USA, Inc. | 1 | $50 |
| Convatec Inc. | 1 | $48 |
| Axonics, Inc. | 2 | $34 |
| Coloplast | 1 | $30 |
| Meditrina | 1 | $29 |
| Innovation Technologies Inc | 1 | $28 |
| Medtronic | 1 | $27 |
| Evofem Biosciences, Inc. | 1 | $17 |
| Bayer | 1 | $16 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$1,375
- Orilissa$241
- ACESSA PROVU SYSTEM$130
- AIRSEAL$124
- iFuse Implant$124
- ORIAHNN$119
- PROGEL$106
- MAKENA$102
- Uterine Manipulators & Injectors$100
How this compares
$3,495 in reported general payments places this provider in the 70th percentile of 396 obstetrics & gynecology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Tulsa
- Joseph NemcokTulsa$632K
- Jay WilliamsonTulsa$130K
- Lori HubbardTulsa$41K
- Micah RelicTulsa$20K
- Bryan RoehlTulsa$15K
- Timmeni StevensTulsa$14K
- Rachel GibbsTulsa$12K
- Thomas LaneTulsa$11K
- Carlos GuevaraTulsa$11K
- David CameronTulsa$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.